Recombinant Anti-CD55 x Anti-HLA-A Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD55 antibody are both extended with the scFv fragment from an anti-HLA-A antibody. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY